lobbying_activities: 2682554

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2682554	a3df2660-d18e-4b67-86cf-7312571df5c8	Q3	MARSHALL & POPP, LLC	401105121	AMGEN USA INC.	2021	third_quarter	CPT	Issues related to intellectual property and patent reform, including S.1435, the Affordable Prescriptions for Patients Act and S.1260, the United States Innovation and Competition Act.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2021-10-16T08:51:29.393000-04:00